EUCAST News

19 Apr 2015

EUCAST breakpoints for dalbavancin, oritavancin and tedizolid released.

The new agents dalbavancin, oritavancin and tedizolid have been approved by EMA (the European Medicines Agency) with breakpoints determined by EUCAST.